{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:02:35Z","timestamp":1761894155930,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":6338,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1111\/j.1600-6143.2005.00948.x","type":"journal-article","created":{"date-parts":[[2005,7,4]],"date-time":"2005-07-04T10:45:22Z","timestamp":1120473922000},"page":"2070-2073","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Successful Treatment of T\u2010cell Post\u2010Transplant Lymphoproliferative Disorder with the Retinoid Analog Bexarotene"],"prefix":"10.1016","volume":"5","author":[{"given":"Donald E.","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole A.","family":"Aqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan T.","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy D.","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunita D.","family":"Nasta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mariusz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2005.00948.x_bib1","first-page":"139","article-title":"Posttransplantation lymphoproliferative disorders (PTLD): current perspectives","volume":"8","author":"Nalesnik","year":"1996","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib2","first-page":"106","article-title":"Malignant lymphomas in transplantation patients","volume":"1","author":"Penn","year":"1969","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib3","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long\u2010 term follow\u2010up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib4","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2000.18.21.3622","article-title":"Durable remission after aggressive chemotherapy for very late post\u2010kidney transplant lymphoproliferation: A report of 16 cases observed in a single center","volume":"18","author":"Mamzer\u2010Bruneel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib5","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood.V86.9.3333.bloodjournal8693333","article-title":"Aggressive treatment for postcardiac transplant lymphoproliferation","volume":"86","author":"Swinnen","year":"1995","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti\u2010CD20 monoclonal antibody (Rituximab) in post transplant B\u2010lymphopoliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib7","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1111\/j.1600-6143.2004.00521.x","article-title":"Post transplant T\u2010cell lymphoma: a case series of four patients from a single unit and review of the literature","volume":"4","author":"Rajakariar","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib8","first-page":"877","article-title":"Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine\u2010based immunosuppression","volume":"10","author":"Armitage","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(84)90994-2","article-title":"Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin\u2010steroid therapy","volume":"1","author":"Starzl","year":"1984","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0011-3840(88)90011-1","article-title":"The diagnosis and treatment of posttransplant lymphoproliferative disorders","volume":"25","author":"Nalesnik","year":"1988","journal-title":"Curr Probl Surg"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pbc.20231","article-title":"Epstein\u2010Barr virus\u2010associated peripheral T\u2010cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature","volume":"44","author":"George","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib12","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1021\/jm00044a014","article-title":"Synthesis and structure\u2010activity relationship of novel retinoid X receptor\u2010selective retinoids","volume":"37","author":"Boehm","year":"1994","journal-title":"J Med Chem"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib13","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1200\/JCO.2001.19.9.2456","article-title":"Bexarotene is effective and safe for treatment of refractory advanced stage cutaneous T cell lymphoma: multinational phase II\u2010III trial results","volume":"19","author":"Duvic","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1600-6143.2005.00948.x_bib14","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1200\/JCO.2003.05.068","article-title":"Multicenter phase II study of oral bexarotene for patients with metastatic breast cancer","volume":"21","author":"Esteva","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2005.00948.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522127012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522127012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2005.00948.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:35:42Z","timestamp":1761626142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522127012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S1600613522127012"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00948.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2005,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Treatment of T\u2010cell Post\u2010Transplant Lymphoproliferative Disorder with the Retinoid Analog Bexarotene","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.00948.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}